Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Trading Update

13 Feb 2025 07:00

RNS Number : 9162W
Gattaca PLC
13 February 2025
 

13 February 2025

 

Gattaca plc

 

("Gattaca" or the "Group")

 

Trading Update

 

Robust performance in line with expectations

 

Gattaca plc, the specialist staffing solutions business, is pleased to provide the following trading update for the six months ended 31 January 2025 ("H1 25").

 

· Group Net Fee Income1 ("NFI") expected to be £18.8m (H1 242 £19.4m), a decrease of 3% year-on-year ("YoY").

 

· Contract NFI was down 1% year on year, driven by growth in contractors out and timesheet value, offset by increased contractor holiday during the summer and new year periods.

 

· Permanent NFI down 10% YoY, H1 25 was up 3% on H2 24, reflecting sequential growth.

 

· Statement of Work ("SoW") NFI was down 3% YoY, as new client acquisitions partially offset delays linked to the public sector spend review.

 

· Total Group headcount reduced by 12% YoY, with sales headcount reduced by 10% as the Group focused on operational efficiency and resource allocation with headcount investment targeted at sectors showing growth opportunities. Sales to Support mix improved to 71:29 (31 January 2024: 69:31).

 

· The Group expects to report statutory net cash as at 31 January 2025 of £16.7m (31 January 2024: net cash of £22.3m). Days sales outstanding (DSO) remains in line with recent reported trends, the decrease in net cash is primarily a reduction in trade creditors.

 

 

Outlook

 

· Group guidance for FY25 adjusted profit before tax remains at £3m.

 

· The Group expects to announce an interim dividend at its Interim Results.

 

 

Notice of Interim Results

The Group will announce its results for the six months to 31 January 2025 on Wednesday 2 April 2025.

 

 

Matthew Wragg, Chief Executive Officer said:

"I am pleased to report that the Group is trading in line with expectations. Our strategic investments in growth opportunities are delivering positive momentum and our other sectors are proving resilient. The Group continues to operate in a tough market environment, however with targeted investments in core sectors we remain focused on delivering long-term growth. We are confident that we will navigate the current conditions through strong engagement, high productivity, operational efficiency and active management of the Group's cost base."

 

1. NFI is calculated as revenue less contractor payroll costs

2. H1 24 results have been restated for the discontinuing of our US-based operations which were exited in H2 2024 and are treated as discontinued operations. The aggregated impact of these items on H1 24 reported NFI is £0.2m reduction.

 

 

For further information please contact:

 

Gattaca plc

+44 (0) 1489 898989

Matthew Wragg, Chief Executive Officer 

Oliver Whittaker, Chief Financial Officer

Panmure Liberum Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Richard Lindley

Edward Mansfield

Will King

IFC Advisory (Financial PR and IR)

+44 (0) 203 934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDLLFFELLLBBL
Date   Source Headline
14th May 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 20267:00 amRNSInterim Results
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Feb 20267:00 amRNSTrading Update
31st Dec 20257:00 amRNSDirector/PDMR dealing
31st Dec 20257:00 amRNSDirector/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
16th Dec 202512:19 pmRNSExercise of Options and Director/PDMR Shareholding
11th Dec 20259:05 amRNSResults of Annual General Meeting
10th Nov 20257:00 amRNSAvailability of Report & Accounts and AGM Notice
23rd Oct 20257:00 amRNSFinal results for the year ended 31 July 2025
15th Oct 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
13th Oct 20252:59 pmRNSBlock Listing Six Monthly return
8th Oct 20257:00 amRNSNotice of Results
5th Aug 20257:00 amRNSTrading update and Acquisition
22nd Jul 20257:00 amRNSEBT Share Purchase Programme
21st Jul 20256:22 pmRNSExercise of Options and Director/PDMR Shareholding
2nd Apr 20252:21 pmRNSCORRECTION – Interim Results
2nd Apr 20257:00 amRNSInterim Results
1st Apr 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Feb 20257:00 amRNSTrading Update
27th Jan 20254:51 pmRNSFurther re EBT Share Purchase Programme
11th Dec 20243:59 pmRNSDirector/PDMR Shareholding
11th Dec 20242:25 pmRNSResult of AGM
11th Nov 20242:29 pmRNSAvailability of Report & Accounts and AGM Notice
30th Oct 20247:00 amRNSEBT Share Purchase Programme
24th Oct 20247:00 amRNSFinal results for the year ended 31 July 2024
1st Oct 20247:00 amRNSBlock listing Six Monthly Return
15th Aug 20247:00 amRNSTrading Update for the year ended 31 July 2024
16th Jul 202410:36 amRNSDirector/PDMR Share Purchase
11th Jul 202411:13 amRNSExercise of Options
1st Jul 20247:00 amRNSNominated Adviser and Broker
16th Apr 20247:00 amRNSInterim Results
2nd Apr 20247:00 amRNSBlock listing six monthly return
15th Feb 20247:00 amRNSTrading Update
25th Jan 20247:00 amRNSExercise of Options
6th Dec 20235:07 pmRNSDirector/PDMR Shareholding
6th Dec 20234:51 pmRNSResults of Annual General Meeting
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.